Endometrial Thickness in Asymptomatic
Patients Taking Tamoxifen
DOWNLOAD FACT SHEET IN PDF

References:

1) Tamoxifen and Uterine Cancer. ACOG Committee Opinion No. 336. Obstet Gynecol
2006;107:1475-1478 [PDF]

2) Suh-Burgmann EJ, Goodman A. Surveillance for Endometrial Cancer in Women Receiving
Tamoxifen. Ann Intern Med 1999;131:127-135 [PDF]

3) Fong K, Causer P, Atri M. Transvaginal US and Hysterosonography in Postmenopausal
Women with Breast Cancer Receiving Tamoxifen: Correlation with Hysteroscopy and
Pathologic Study. Radiographics 2003;23:137-155 [PDF]

4) Hann LE, Gretz EM, Bach AM. Sonohysterography for Evaluation of the Endometrium in
Women Treated with Tamoxifen. AJR 2001;177:337-342 [PDF]

5) Ascher SM, Imaoka I, Lage JM. Tamoxifen-induced Uterine Abnormalities: The Role of
Imaging. Radiology 2000;214:29-38 [PDF]

6) Hann LE, Giess CS, Bach AM. Endometrial Thickness in Tamoxifen-Treated Patients:
Correlation with Clinical and Pathologic Findings. AJR 1997;168:675-661 [PDF]